The National Cancer Institute experience with early and late effects of combined modality therapy in small cell lung cancer

Antibiot Chemother (1971). 1988:41:210-2. doi: 10.1159/000416206.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma, Small Cell / drug therapy
  • Carcinoma, Small Cell / mortality
  • Carcinoma, Small Cell / radiotherapy
  • Carcinoma, Small Cell / therapy*
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Female
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / mortality
  • Lung Neoplasms / radiotherapy
  • Lung Neoplasms / therapy*
  • Male
  • National Institutes of Health (U.S.)
  • Radiation Injuries
  • Time Factors
  • United States